Sermorelin 2mg
CAS: 86168-78-7
Sermorelin 2mg by BioPeptides is a research-grade synthetic peptide corresponding to the biologically active GHRH (1-29) fragment. It is widely used in laboratory investigations examining growth hormone signaling pathways, peptide-receptor activation, and endocrine communication mechanisms. Produced using precision peptide synthesis and analytically verified for stability and purity, Sermorelin supports reproducible experimental models studying pituitary signaling and GH axis regulation.
$115.00
Research Use Only
Research Overview
Sermorelin is a synthetic analog of growth hormone–releasing hormone corresponding to the biologically active GHRH (1-29) fragment.
In laboratory research settings, Sermorelin is studied for its role in stimulating GH signaling through GHRH receptor activation.
Researchers investigate its effects within pituitary signaling systems and endocrine regulatory pathways.
The peptide supports mechanistic studies examining growth hormone secretion dynamics and peptide-mediated cellular communication.
Scientific Background
Growth hormone secretion is regulated by hypothalamic signaling peptides such as growth hormone–releasing hormone (GHRH).
Sermorelin represents the first 29 amino acids of the native GHRH sequence, which contain the biologically active region responsible for receptor activation.
In research models, Sermorelin interacts with GHRH receptors located in the pituitary gland, initiating downstream growth hormone signaling pathways.
This mechanism makes Sermorelin valuable for experimental investigations focused on endocrine regulation and peptide signaling dynamics.
Mechanistic Research Perspective
- GHRH receptor activation research
- Growth hormone secretion pathway studies
- Endocrine regulatory signaling investigations
- Peptide-receptor interaction analysis
- Pituitary signaling pathway exploration
Primary Research Applications
Growth Hormone Signaling Research: Used to examine GH release mechanisms through activation of the GHRH receptor pathway.
Endocrine Pathway Studies: Researchers analyze hormone regulation, feedback loops, and peptide-mediated endocrine communication.
Peptide-Receptor Interaction Research: Applied in laboratory assays exploring receptor binding affinity, signaling activation, and pathway specificity.
Molecular and Cellular Biology: Used in controlled in-vitro studies investigating peptide-driven cellular signaling and communication pathways.
Comparative GH Peptide Research: Supports comparative studies between Sermorelin and other GH-related peptides such as Mod-GRF.
Molecular Characteristics
- Compound Name: Sermorelin
- CAS Number: 86168-78-7
- Peptide Type: GHRH (1-29) analog
- Peptide Class: Growth hormone signaling peptide
- Form: Lyophilized peptide powder
- Unit Size: 2 mg research peptide
Stability Profile and Storage Recommendations
- Store lyophilized peptide at −20°C
- Protect from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after each use
Solubility and Preparation Considerations
- Soluble in sterile aqueous laboratory solutions
- Compatible with buffered peptide research systems
- Applicable in endocrine signaling assays
- Suitable for receptor signaling experiments
- Compatible with molecular biology research protocols
Technical Specifications
product Name
Sermorelin 2mg
brand
BioPeptides
purity
Research-grade analytical quality
form
Lyophilized peptide powder
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
Identity and purity verification
molecular Structure
GHRH (1-29) peptide analog
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- Molecular identity verification
- Purity and stability assessment
- Structural integrity testing
- Batch-to-batch consistency validation
- Analytical quality control inspection
Frequently Asked Questions
Sermorelin is used in laboratory studies examining growth hormone–releasing hormone signaling, GH secretion mechanisms, and endocrine pathway regulation.
GHRH (1-29) refers to the first 29 amino acids of growth hormone–releasing hormone, representing the biologically active portion responsible for receptor activation.
CAS 86168-78-7 uniquely identifies Sermorelin and ensures accurate chemical documentation and reproducibility across research laboratories.
Yes. Sermorelin is widely used in controlled laboratory experiments investigating receptor activation and endocrine signaling pathways.
It is commonly studied in endocrinology research, peptide signaling research, molecular biology, and growth hormone pathway investigations.
The 2mg research format supports pilot studies, method development, and focused experiments requiring precise peptide quantities.
It should be stored at −20°C and protected from light and moisture.